Jeil Pharma Holdings (XKRX:002620) Accounts Payable & Accrued Expense : ₩189,697 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Jeil Pharma Holdings Accounts Payable & Accrued Expense?

Jeil Pharma Holdings's quarterly accounts payable & accrued expense declined from Sep. 2023 (₩192,449 Mil) to Dec. 2023 (₩183,691 Mil) but then increased from Dec. 2023 (₩183,691 Mil) to Mar. 2024 (₩189,697 Mil).

Jeil Pharma Holdings's annual accounts payable & accrued expense increased from Dec. 2021 (₩179,426 Mil) to Dec. 2022 (₩189,457 Mil) but then declined from Dec. 2022 (₩189,457 Mil) to Dec. 2023 (₩183,691 Mil).

Jeil Pharma Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for Jeil Pharma Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jeil Pharma Holdings Accounts Payable & Accrued Expense Chart

Jeil Pharma Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

184,979.55

168,707.57

179,426.50

189,457.24

183,690.95

Jeil Pharma Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															189,246.00	182,773.74	192,449.22	183,690.95	189,697.17

Jeil Pharma Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Jeil Pharma Holdings (XKRX:002620) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jeil Pharma Holdings Inc (XKRX:002620) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

745-5, Banpo-dong, Seocho-gu, Seoul, KOR, 137-810

Website

https://www.jeilpharm.co.kr

Jeil Pharma Holdings Inc is involved in manufacture and distribution of pharmaceutical products. The company mainly produces finished pharmaceutical products and active pharmaceutical ingredients. It has categorized its products in Antibiotic, Oncology, Cardiovascular, Gastrointestinal, Urology, Respiratory etc. The firm's manufacturing facility and research and development institute located at Yongin-si, Gyeonggi-do in Korea.

Jeil Pharma Holdings (XKRX:002620) Headlines

No Headlines